Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2009
06/17/2009CN100500662C Alkyl ether derivatives or salts thereof
06/16/2009US7547782 Met kinase inhibitors
06/16/2009US7547710 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance
06/16/2009US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents
06/16/2009US7547696 Aminoquinoline derivatives and their use as adenosine A3 ligands
06/16/2009US7547691 Such as 2-{5-Methyl-2-[3-(4-methylpiperazin-1-yl)-propylamino]-pyrimidin-4-yl}-benzo[b]thiophene-4-carboxylic acid methylamide; inhibitory Kappa-B protein inhibitors (IKK); rheumatoid arthritis and chronic obstructive pulmonary disease
06/16/2009US7547685 Therapeutic substituted pyrrolidone compounds
06/16/2009US7547660 Phenyl-substituted 4-hydroxy-tetrahydropyridones
06/16/2009CA2452217C Hiv inhibiting pyrimidines derivatives
06/16/2009CA2451474C Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
06/16/2009CA2202032C Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
06/11/2009WO2009072649A1 4-arylphenyl derivative
06/11/2009WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound
06/11/2009WO2009072581A1 Lactam compound or salt thereof, and ppar activator
06/11/2009WO2009072267A1 Abcg2 inhibitor
06/11/2009WO2009071535A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
06/11/2009WO2009070869A1 Renin inhibitors
06/11/2009WO2009055289A3 Therapeutic substituted lactams
06/11/2009US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines
06/11/2009US20090149528 Cinnamic acid amides
06/11/2009US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders
06/11/2009US20090149470 aurora kinase inhibitors; 2-(thiazol-2-ylamino)pyridine compounds as antitumor agents; 6-((4-(3-chloro-2-fluorobenzoyl)piperazin-1-yl)methyl)-N-thiazol-2-ylpyridin-2-amine for example
06/11/2009US20090149463 Therapeutic agents
06/11/2009US20090149460 New Compounds
06/11/2009US20090149457 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
06/11/2009US20090149438 Pyrimidines as PLK inhibitors
06/11/2009CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound
06/11/2009CA2707718A1 Abcg2 inhibitor
06/11/2009CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
06/11/2009CA2707565A1 Renin inhibitors
06/10/2009EP2066660A2 Therapeutic lactams
06/10/2009EP2066654A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators
06/10/2009EP2066653A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
06/10/2009EP2066643A1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides and against arthropods
06/10/2009EP2066637A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands
06/10/2009EP2066627A1 Novel minor groove binders
06/10/2009EP2066318A2 Oxindole derivatives as anticancer agents
06/10/2009EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
06/10/2009EP0976737B1 Pyrazole derivatives, process for preparing the same, intermediates, and pest control agent containing the same as active ingredient
06/10/2009CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/10/2009CN100497334C Indole derivatives useful as histamine h3 antagonists
06/10/2009CN100497314C Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
06/10/2009CN100496490C Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
06/09/2009US7544803 2-(2,2,2-Trifluoro-ethyl)-1,2,3,4-tetrahydro-isoquinoline-6-carboxylic acid quinolin-7-ylamides; treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, arthritis, gastrointestinal disorders
06/09/2009US7544707 Peroxisome Proliferator Activated Receptor (PPAR); 2-Methyl-4-[2-(4-trifluoromethylphenyl)-2H-indazol-7-ylmethylsulfanyl]phenoxyacetic Acid; diabetes, Metabolic and cardiovascular disorders, arthritis, demyelinating diseases
06/09/2009US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity
06/09/2009US7544701 Central nervous system disorders; psychological disorders
06/09/2009US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders
06/09/2009US7544690 MCH receptor antagonists
06/09/2009US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
06/09/2009US7544312 Charge transport compositions and electronic devices made with such compositions
06/09/2009CA2583764C Thrombopoietin activity modulating compounds and methods
06/04/2009WO2009070045A2 Imidazole derivatives, process for their preparation, and thier pharmaceutical use
06/04/2009WO2009069687A1 Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element
06/04/2009WO2009068652A1 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines as soluble guanylate cyclase activators
06/04/2009WO2009068468A2 Pyridine compounds
06/04/2009WO2009045992A3 C-met protein kinase inhibitors
06/04/2009WO2009004427A3 Benzimidazole derivatives
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/04/2009US20090143575 Vanilloid receptor ligands and their use in treatments
06/04/2009US20090143439 New pyridines as fbpase inhibitors for treatment of diabetes
06/04/2009US20090143437 Ep4 receptor antagonists
06/04/2009US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
06/04/2009US20090143394 Compounds for activating tgf-beta signaling
06/04/2009US20090143386 Human adam-10 inhibitors
06/04/2009US20090143384 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer
06/04/2009US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors
06/04/2009US20090142297 5-substituted isoindoline compounds
06/04/2009CA2706576A1 Pyridine compounds
06/03/2009EP2065377A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
06/03/2009EP2065368A1 Inhibitors of IAP
06/03/2009EP2064206A2 Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride
06/03/2009EP2064193A1 Heterocyclic gpr40 modulators
06/03/2009EP2064190A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
06/03/2009EP2064185A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions
06/03/2009EP1910310B1 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
06/03/2009EP1660077B1 Indol-6 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009EP1648446B1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009EP1648445B1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009EP1648444B1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
06/03/2009EP1399440B1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors
06/03/2009EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
06/03/2009EP1165553B1 C10 ester substituted taxanes as antitumor agents
06/03/2009EP1071668B1 5-aminoindeno[1,2-c]pyrazol-4-ones as anti-cancer and anti-proliferative agents
06/03/2009CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
06/03/2009CN100494182C Regulatory factor of tumor necrosis alpha factor
06/03/2009CN100494180C Preparation method and uses of isoquinolinium compound and its salt
06/02/2009US7541472 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
06/02/2009US7541425 Mono-, oligo- and poly(3-alkynylthiophenes) and their use as charge transport materials
06/02/2009US7541381 Sulfur compounds such as 3-((4-chloroanilino)sulfonyl)thio-phene-2-carboxylic acid, used as enzymes inhibitors for prophylaxis of antibiotic resistant bacterial infections
06/02/2009US7541370 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
06/02/2009US7541369 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2009US7541368 Pyrazoles as inhibitors of tumor necrosis factor
06/02/2009US7541358 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
06/02/2009CA2434277C Substituted alkylamine derivatives and methods of use
06/02/2009CA2287551C 3-(2-pyrrolidinylmethyl)-indole compounds having 5-ht6 affinity
06/02/2009CA2258539C Ring-fused dihydropyranes, process for the preparation and use thereof
05/2009
05/28/2009WO2009067401A1 Cycloalkyloxy-and hetξrocycloalky- loxypyridine compounds as modulators of the histamine h3 receptor
05/28/2009WO2009065854A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors